Simulations Plus

SLP

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a leading provider of clinical trial data analysis and consulting services.

Simulations Plus has been a target of short sellers for a while. The current short interest of 14.03% is significantly above the average of the last 12 months (7.30%).